Insider trades
Open-market buys and sales that US company officers, directors and 10% owners file, newest filing first.
| Trade type | ||||||||
|---|---|---|---|---|---|---|---|---|
Zenas BioPharmaZBIO | Open-market buy | 05/18 | 05/18 | 60,000 sh | $16.88 | $1,012,800 | +162.5% | |
Zenas BioPharmaZBIO | Open-market buy | 04/28–04/29 | 04/29 | 60,000 sh2 trades | $17.79avg. | $1,067,200 | +3.5% | |
Hongbo LuDirector | Zenas BioPharmaZBIO | Open-market buy | 03/31 | 04/02 | 3,768 sh | $18.63 | $70,197.84 | +0.9% |
Peter Evan HarwinDirector | Zenas BioPharmaZBIO | Open-market buy | 03/31 | 04/01 | 150,000 sh | $20.00 | $3,000,000 | +6.8% |
Fairmount Healthcare Fund IIDirector | Zenas BioPharmaZBIO | Open-market buy | 03/31 | 04/01 | 150,000 sh | $20.00 | $3,000,000 | +6.8% |
Fairmount Funds ManagementDirector | Zenas BioPharmaZBIO | Open-market buy | 03/31 | 04/01 | 150,000 sh | $20.00 | $3,000,000 | +6.8% |
Tomas KiselakDirector | Zenas BioPharmaZBIO | Open-market buy | 03/31 | 04/01 | 150,000 sh | $20.00 | $3,000,000 | +6.8% |
Zenas BioPharmaZBIO | Open-market buy | 03/30–03/31 | 03/31 | 54,000 sh2 trades | $18.91avg. | $1,021,140 | +3.2% | |
Hongbo LuDirector | Zenas BioPharmaZBIO | Open-market buy | 03/31 | 03/31 | 75,000 sh | $20.00 | $1,500,000 | +21.6% |
Zenas BioPharmaZBIO | Open-market buy | 02/12–02/13 | 02/13 | 19,860 sh4 trades | $25.16avg. | $499,745.6 | No record | |
Hongbo LuDirector | Zenas BioPharmaZBIO | Open-market buy | 02/11 | 02/13 | 25,985 sh | $22.50 | $584,662.5 | +8.1% |
Zenas BioPharmaZBIO | Open-market buy | 02/02 | 02/03 | 57,000 sh | $17.96 | $1,023,720 | +15.6% | |
Zenas BioPharmaZBIO | Open-market buy | 01/07–01/09 | 01/09 | 100,000 sh3 trades | $16.39avg. | $1,639,000 | +37.6% | |
Zenas BioPharmaZBIO | Open-market buy | 25/10/09 | 25/10/14 | 117,255 sh2 trades | $19.19avg. | $2,250,026.5 | No record | |
Jason Raleigh NunnDirector | Zenas BioPharmaZBIO | Open-market buy | 25/10/09 | 25/10/14 | 63,158 sh | $19.00 | $1,200,002 | +5.7% |
10% Owner | Zenas BioPharmaZBIO | Open-market buy | 25/10/09 | 25/10/14 | 126,315 sh2 trades | $19.00avg. | $2,399,985 | +7.1% |
Zenas BioPharmaZBIO | Open-market buy | 25/10/09 | 25/10/14 | 126,315 sh2 trades | $19.00avg. | $2,399,985 | +7.1% | |
Leon O. Moulder Jr.SEE REMARKS | Zenas BioPharmaZBIO | Open-market buy | 25/10/07 | 25/10/09 | 36,928 sh | $20.85 | $769,948.8 | No record |
Peter Evan HarwinDirector | Zenas BioPharmaZBIO | Open-market buy | 25/10/07 | 25/10/09 | 316,219 sh | $19.00 | $6,008,161 | +16.7% |
Zenas BioPharmaZBIO | Open-market buy | 24/09/13–25/10/07 | 25/10/09 | 321,983 sh2 trades | $18.63avg. | $6,000,031 | No record |
